In the BioHarmony Drug Report Database

"Preview" Icon

Tomivosertib

Tomivosertib is a small molecule pharmaceutical. It is currently being investigated in clinical studies. The pharmaceutical is active against MAP kinase-interacting serine/threonine-protein kinase 2 and MAP kinase-interacting serine/threonine-protein kinase 1. In addition, it is known to target serine/threonine-protein kinase 17A and dual specificity protein kinase CLK4.

 

Trade Name

 

 

Common Name

 

tomivosertib
 

ChEMBL ID

 

CHEMBL4073443
 

Indication

 

 

Drug Class

 

Serine/threonine kinase inhibitors

Image (chem structure or protein)

Tomivosertib structure rendering